The efficacy and safety of Traditional Chinese Medicine (Jiang Zhi Granule) for nonalcoholic fatty liver: A multicenter, randomized, placebo-controlled study

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Pan, Jielu ^a   Wang, Miao ^a   Song, Haiyan ^a   Wang, Lin ^a   Ji, Guang ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893735937     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/965723     Document Type: Article

References (18)

1. Angulo P., Medical progress: nonalcoholic fatty liver disease. The New England Journal of Medicine 2002 346 16 1221 1231 2-s2.0-0037129380 10.1056/NEJMra011775 (Pubitemid 34984585)
2. Ruhl C. E., Everhart J. E., Epidemiology of nonalcoholic fatty liver. Clinics in Liver Disease 2004 8 3 501 519 2-s2.0-4344582117 10.1016/j.cld.2004. 04.008 (Pubitemid 39141139)
3. Nugent C., Younossi Z. M., Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology and Hepatology 2007 4 8 432 441 2-s2.0-34547683485 10.1038/ncpgasthep0879 (Pubitemid 47208893)
4. Marchesini G., Brizi M., Blanchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N., Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 8 1844 1850 2-s2.0-0035431018 (Pubitemid 33641605)
5. Malaguarnera M., Di Rosa M., Nicoletti F., Malaguarnera L., Molecular mechanisms involved in NAFLD progression. Journal of Molecular Medicine 2009 87 7 679 695 2-s2.0-67649448956 10.1007/s00109-009-0464-1
6. Loria P., Adinolfi L. E., Bellentani S., Bugianesi E., Grieco A., Fargion S., Gasbarrini A., Loguercio C., Lonardo A., Marchesini G., Marra F., Persico M., Prati D., Baroni G. S., Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Digestive and Liver Disease 2010 42 4 272 282 10.1016/j.dld.2010.01.021
7. Méndez-Sánchez N., Arrese M., Zamora-Valdés D., Uribe M., Treating nonalcoholic fatty liver disease. Liver International 2007 27 9 1157 1165 2-s2.0-35148820177 10.1111/j.1478-3231.2007.01567.x (Pubitemid 47543143)
8. Wang M., Sun S., Wu T., Zhang L., Song H., Hao W., Zheng P., Xing L., Ji G., Inhibition of LXRalpha/SREBP-1c-mediated hepatic steatosis by Jiang-Zhi granule. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 584634 10.1155/2013/584634
9. Yang L.-L., Wang M., Liu T., Song H.-Y., Li D.-F., Zheng P.-Y., Liu P., Ji G., Effects of Chinese herbal medicine Jiangzhi granule on expressions of liver X receptor a and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease. Journal of Chinese Integrative Medicine 2011 9 9 998 1004 2-s2.0-80053204882 10.3736/jcim20110911
10. Song H. Y., Zhang L., Pan J. L., Yang L. L., Ji G., Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of Integrative Medicine 2013 11 4 262 268
11. Zeng M. D., Fan J. G., Lu L. G., Li Y. M., Chen C. W., Wang B. Y., Mao Y. M., Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. Journal of Digestive Diseases 2008 9 2 108 112 2-s2.0-42449155505 10.1111/j.1751-2980.2008.00331.x (Pubitemid 351566633)
12. Moher D., Schulz K. F., Altman D. G., The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Podiatric Medical Association 2001 91 8 437 442 2-s2.0-0035462999
13. Longo R., Ricci C., Masutti F., Vidimari R., Croce L. S., Bercich L., Tiribelli C., Palma L. D., Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Investigative Radiology 1993 28 4 297 302 2-s2.0-0027585532 (Pubitemid 24079682)
14. Ataseven H., Yildirim M. H., Yalniz M., Bahcecioglu I. H., Ozercan I. H., Celebi S., Demir A., Correlation between calibrated computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis. Journal of Hepatology 2003 38 supplement 2 204
15. Bellentani S., Marino M., Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology 2009 8 1 S4 S8 2-s2.0-66749106254
16. Lu Y.-L., Wang M., Zhang L., He Y.-Q., Yang L., Wang C.-H., Wang Z.-T., Ji G., Simultaneous determination of six components in the 'Jiang-Zhi' granule by UPLC-MS analysis. Chinese Journal of Natural Medicines 2010 8 6 449 455 2-s2.0-78650906278 10.1016/S1875-5364(11)60007-1
17. Miao W., Tao L., Hua-feng W., Lian-jun X., Peng-yong Z., Guang J., Clinical study of Jiangzhi Granule and behavioral intervention for nonalcoholic fatty liver disease of phlegm and blood-stasis syndrome. Shanghai Journal of Traditional Chinese Medicine 2010 4
18. Zhang L., Zheng P., Ji G., Jiangzhi granula ameliorate hepatic steatosis via improving leptin resistance in high-fat diet induced NAFLD rats. Hepatology International 2011 5 177